Globus Medical Short Interest Declines Significantly

Medical device company sees 14% drop in shares sold short as stock price rises

Apr. 17, 2026 at 5:08pm

Got story updates? Submit your updates here. ›

An extreme close-up of highly detailed, industrial-grade medical equipment and tools in muted shades of grey, conveying the advanced technology and precision engineering that defines Globus Medical's products.Globus Medical's state-of-the-art manufacturing capabilities underpin its position as a leading innovator in the medical device industry.Audubon Today

Globus Medical, Inc. (NYSE:GMED), a leading manufacturer of spinal and orthopedic implants, saw a significant decline in short interest during March. The number of shares sold short dropped 14% from mid-March to the end of the month, indicating reduced bearish sentiment around the stock.

Why it matters

The drop in short interest suggests increased investor confidence in Globus Medical's business performance and growth prospects. As a major player in the medical device industry, the company's stock movements and short-selling activity can provide insights into broader market trends and sentiment around the healthcare sector.

The details

As of March 31st, Globus Medical had 2,831,226 shares sold short, down from 3,293,919 shares on March 15th. This represents about 2.6% of the company's total outstanding shares. The average daily trading volume is 991,496 shares, putting the current short interest ratio at 2.9 days to cover.

  • Short interest data is reported twice monthly, with the March 15th and March 31st figures cited.
  • Globus Medical's stock price has risen steadily in recent months, reaching a 52-week high of $101.40.

The players

Globus Medical, Inc.

A leading medical device company specializing in spinal and orthopedic implants and surgical instruments.

SBI Securities Co. Ltd.

An institutional investor that increased its stake in Globus Medical by 98.2% in the fourth quarter.

Got photos? Submit your photos here. ›

What they’re saying

“Globus Medical's stock performance and declining short interest suggest growing investor confidence in the company's growth prospects within the medical device industry.”

— Analyst

What’s next

Investors will continue to monitor Globus Medical's financial results and market share as the company navigates the evolving healthcare landscape. Any further changes in short interest could signal shifting sentiment around the stock.

The takeaway

The drop in short interest for Globus Medical reflects increasing optimism about the company's ability to maintain its leadership position in the spinal and orthopedic device market. This positive trend aligns with the stock's recent price appreciation and suggests the medical device maker is well-positioned for continued growth.